General |
ERDF and Obra Social Caja Madrid remember the situation and desperation of people with rare diseases with testimony in the first person concerned and family and the main study Enserio data.
Read MoreGeneral |
For the first time a drug improves the symptoms of Huntingtons disease.
Read MoreGeneral |
discrimination towards people living with HIV in Spain continues to hamper the response to the epidemic.
-137 specific consultations on violation of rights to people with HIV received in 2009 the service of legal advice of the Observatory of the Observatory of human rights and HIV/AIDS RED2002, 5% more than in 2008.
-discrimination in the field of work is still, as in previous years, the main source of consultation (32%) in the Spanish State, followed by health care (20%) and insurance (11%), according to data of the report made public today
Spain, February 2010. Imagine that you cite the 8 in the morning in fasting for an operation and two in the afternoon say you that you go home without a reasonable justification. Imagine that after a medical check at work not you renew. Imagine that you can not hire a mortgage because no company makes you a life insurance. Imagine that you are going to introduce you to some oppositions and you exclude for medical reasons despite being well on health. Imagine that the people in your neighborhood you judged as having a virus. No need to imagine. All this happened in 2009 and are still happening in 2010 people who see their rights violated by the fact of having HIV.
Thus notes it report of consultations the Observatory of human rights and HIV/AIDS in RED2002 2009. Between 1 January and 31 December, the service of legal advice of the Observatory received 137 specific consultations on violation of rights to people with HIV, 5% more than in 2008 (131).
Discrimination in the field of labour remains the main source of consultation (32%). Within this area, the most common reasons are: changes in the conditions of work (time, physical location, responsibilities, salary), violation of the confidentiality of medical data, request for the HIV test without having relevance to the post, exclusion of opposition, difficulties in finding work or dismissals.
Other grounds for consulta:
They have highlighted health care (20%), where we are in violation of the confidentiality, inadequate care or degrading treatment; and insurance (11%), where will continue to deny mortgages to people with HIV to not take out insurance for life.
Average age of people served: 37 years
sex of the people served: 38% women and 69% men
by nacionalidad: 72 per cent of the consultations are performed by people of Spanish nationality, while 10% are carried out by people of other nationalities. These numbers might qualify given that 18% of people do not reveal their origin and that in cases brought by third parties (NGOs, hospitals, etc.) can skew the data.
Geographical origin of the consulta: covers the whole State territory, because they have been received of 15 autonomous communities different, most of the more populated areas: Catalonia, Valencia, Andalusia and autonomous community of Madrid.
Via main knowledge of the observatorio: own NGOs, which are those who inform their users of the possibility of using our service. Another important part of people discover it through the Internet and communication media
Conclusión:
The registration of cases, beyond make a picture every year profile of situations of discrimination, allows us to have tangible proof of the violation of the fundamental rights of people with HIV. The reports of the Observatory provide data that highlights the persistence of discrimination and we legitimize to continue working to reduce the stigma and defend the rights of people with HIV.
It is shown that the stigmatization of people living with HIV is a major barriers in the control of the epidemic. The prejudices and ignorance perpetuates a stigma that instills fear in society, exposed to the person concerned to the violation of their rights and makes less effective public health strategies as prevention, care, and the extension of the test.
To respond to this situation in 2003 the Observatory of human rights was created and HIV/AIDS as a project RED2002, funded by the National Plan of the AIDS of the Ministry of health and Social policy, with the goals of addressing stigma and discrimination associated with HIV, visible cases of violation of rights and sensitizing the population on this situation. For this reason, its activities develops free confidential legal advice service. All those people who live in Spain and consider that they have received discriminatory treatment related to HIV, can contact this advice service through your email, website, telephone and postal mail.
Read MoreGeneral |
the project mauve offer today in Valencia a lecture directed to people with discapacidad sensorial.
It will take place at the premises of the Valencian Association of deaf people.
Valencia, February 2010.- Health Foundation and community, through the mauve project, program of prevention that links domestic violence with alcohol abuse, intends to teach tomorrow Friday, and as a novelty in Valencia, a conference entitled “ alcohol: its effects and its connection with domestic violence ”. Persons with sensory disabilities comprise one of the working groups object of the mauve project, try one of the populations at risk of social exclusion, which implies greater vulnerability by them when it comes to suffer ill-treatment.
Through a practical methodology is intended primarily to these people to reflect on their own relationships. It is on the one hand, give them to know the indicators of a relationship of abuse, in contrast to the indicators of a healthy, equal relationship, providing them with strategies for early detection, enabling them to escape in time from this kind of relationship. And, on the other hand, encourage reflection and awareness with respect to its own level of consumption of alcohol, their motivations for this and the myths behind those expectations of consumption as well as the effects that are already being a reality for them / ACE, and that most likely will appear in the future.
This population deserves close attention to the mauve project, as it expresses the technical team of the program, “ post that available studies indicate that the prevalence of victimization of couple and substance abuse violence is higher in this group compared to the general population, and so it being shown associations seeking initiatives linking both problematic ”.
On the other hand, the mauve project ended last Wednesday 24th, with a very positive balance a university extension of 10-hour course, started on Monday in the facilities of founding (Foundation of solidarity and the volunteer of the Valencian Community).
This training has been directed to both students of the University of Valencia and Futures as professionals in the field of drug addiction, primary care and family violence, and also for those interested in both problematic.
“ From the mauve project – explains the programme technical team – consider that this type of course are of particular relevance and play a double role: on the one hand, the student becomes direct beneficiary of a programme for the prevention of intimate partner abuse and its connection with alcohol abuse. And, on the other hand, it gives professional tools for the job from prevention and intervention futures as that will be ”.
Course has spanned topics such as alcohol and its myths, expectations, and of factors involved in the establishment of the habit of consumption, indicators of abuse and dependence, risks and effects of abuse, as well as domestic violence and their rates, cycle of violence, victims and perpetrator characteristicsexplanatory models, and finally, the link between alcohol abuse and domestic violence. All of this with an eminently practical methodology through audiovisual media, discussion groups, analysis of songs, games roles and case studies for the design of evaluation and intervention.
The mauve project is subsidized by the Ministry of health of the Generalitat Valenciana, the anti-drug agency and the National Plan on drugs.
Read MoreGeneral |
global cervical cancer experts recommend that HPV test is used routinely for primary screening programmes of prevention.
In Catalonia, with the test screening digene HPV QIAGEN detects four times more cancers of neck of uterus and 11 times more cervical abnormalities that screening with PAP.
Madrid, February 2010.- experts present at the Congress of EUROGIN the Virus of human papillomavirus (HPV) of Spain, Germany and Great Britain (European Research Organization on Genital Infection and Neoplasia), held in Monaco, have recommended that HPV DNA test be used routinely as a primary screening, followed by cytology, women from the age of 30.
EUROGIN had submitted new data on the implementation of the HPV test in the Catalonia cervical cancer prevention program. The Silvia doctor of Sanjosé, of the Catalan Institute of Oncology (ICO), said that “ with the test screening digene HPV QIAGEN detected four times more cancers of neck of uterus and 11 times more cervical lesions that screening with PAP ”. Dr. Sanjosé also noted that approximately 30% of women between 25 and 65 not hosting cytology screening programmes offered on Spain and 76% of women diagnosed with cervical cancer do not have been subjected to a cytology in the previous 10 years. Using HPV testing as test of rescue for women over 40 years not undergoing screening scheduled for at least five years and more, “ detect 11 times more CIN 2 and CIN 3 than in the general population of any age range ”, said the expert. This means a prevalence of CIN 2 + 17.3/1000 in testing rescue vs. 1.52/1000 in screening the general population.
For Dr. Xavier Bosch, director of the research programme in epidemiology from the cancer of the Catalan Institute of Oncology (ICO), “ numerous clinical studies have shown year after year enough evidence on how the HPV DNA test provides a sensitivity and greater than cytology long-term protection ”.
In one of the many studies presented this year at EUROGIN, German researchers used the test digene HPV, followed by cytology, as primary screening in women over 29 years of the city of Wolfsburg. The 4.81% 18.393 women offered positive HPV test results and results normal in the cytology within this population, three cases of invasive cervical cancer, 4 cases of adenocarcinoma in situ and 61 CIN3 were detected and none was diagnosed by cytology alone. Of the 134 CIN 3 + found cases, all but one were positive for HPV testing.
One of the authors of this research, the teacher Karl Ulrich Petra, said that “ had a large group of women with atypical squamous cells of undetermined significance or intra-epiteliales lesions squamous of low grade, with the old system of screening, they would have been followed with additional PAP one yeardelaying the possible treatment or creating the conditions to become unidentified cases of advanced lesions ”.
“ And another group of women with CIN3 + had made it 3 PAP with normal results in an interval of twelve months, women whose injuries have not been detected if not for the positive results of the HPV test ”, added.
The researchers concluded that “ the use of HPV primary screening test reduces deaths from cervical cancer and is significantly more effective than cytology in preventing invasive cervical cancer ”.
On the other hand, a large number of clinical studies conducted in countries such as Canada, Sweden, Great Britain, the Netherlands or Italy have shown that the risk of developing an injury CIN 2 + or an invasive cancer after a negative HPV test is very low and that the protection offered by this test persists up to 6 years. Thus, if the HPV test was used as the main test for cervical cancer screening, this strategy would enable a secure extension of the screening interval and would provide significant benefits to women and to the public health system.
About QIAGEN
QIAGEN N.V., a business group of the Netherlands, is the leading global provider of technologies for the realization of samples and trials. QIAGEN has developed and markets over 500 products, as well as solutions automated for such products. The company supplies to laboratories of molecular diagnosis, academic researchers, pharmaceutical companies, biotechnology, and customers who use this evidence in forensic areas, veterinary, food and pharmaceutical process control. QIAGEN assay technologies include one of the largest sets of worldwide molecular diagnostic tests. This set is testing digene HPV, which is considered the “gold standard” tests to detect the high-risk types of HPV, are the leading cause of cervical cancer.
About the test digene HPV
The test digene HPV QIAGEN is approved by United States and Europe for use in conjunction with the Pap smear in women over 30 years. Since 1999 the “ Federal Drug Administration (FDA) ” approved the test, more than 300 articles have been published in specialized journals and more than 825,000 studies in clinical programs to women. More than 40 million of carcinoma of HPV testing has been made with the test digene HPV.
About HPV and cervical cancer
The cervical cancer or cervical cancer affects around of 500,000 women each year worldwide, and after breast cancer, is the second most common in women neoplastic disease. This type of cancer is originating by the high-risk types of the Virus of human papillomavirus (HPV), whose transmission is sexual. It is estimated that 80% of women will have an HPV infection at some point in their lives. However, the infection will disappear in most cases without causing major problems. It is only in cases of persistent infection that can cause abnormal cells that can develop a cervical cancer if not detected and treated before. For more information about HPV and cervical cancer, visit http://www.hpv-test.es.
